For patients obtaining other opioid analgesics and switching to this drug or into the extended-launch formulations of this drug, it can be safer to undervalue a affected person's 24-hour oral prerequisite and provide rescue medication than overestimate and deal with an adverse reaction; There's significant inter-patient variation from the relative